Disciplined Investments, LLC Incyte Corp Transaction History

Disciplined Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$60.95 - $75.51 $121 - $151	-2 Reduced 9.52%	19 $1,000
Q1 2023 May 10, 2023	SELL	$70.23 - $86.01 $70 - $86	-1 Reduced 4.55%	21 $1,000
Q4 2022 Feb 01, 2023	SELL	$67.18 - $84.11 $67 - $84	-1 Reduced 4.35%	22 $1,000
Q2 2022 Aug 09, 2022	BUY	$66.18 - $83.18 $463 - $582	7 Added 43.75%	23 $2,000
Q1 2022 Apr 22, 2022	BUY	$66.02 - $79.71 $1,056 - $1,275	16 New	16 $1,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.